Oncolytics Biotech Says Data Backs Pelareorep in KRAS‑Mutant mCRC
ReutersDec 16, 2025 2:49 PM
Dec 16 (Reuters) - Oncolytics Biotech Inc ONCY.O:
ONCOLYTICS BIOTECH® ANNOUNCES PROMISING EFFICACY AND TRANSLATIONAL DATA SUPPORTING PELAREOREP IN KRAS-MUTANT METASTATIC COLORECTAL CANCER
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Rocket Lab Stock Analysis: Why Is Rocket Lab Stock Price Soaring? Is Now a Good Time To Buy?
TradingKey - Even though Rocket Lab's stock price has seen substantial gains from its previous levels, we believe that Rocket Lab still offers speculative value.TradingKey
2 hours ago
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital baTradingKey
Fri, Dec 19
Musk’s Next Ambition: Building a Space-Based AI Data Center
TradingKey - Musk has long resisted the idea of taking SpaceX public. After the Tesla take-private drama and the resulting SEC penalties (which cost him the chairmanship), he’s been wary of public market entanglements. But something’s changed—and fast.TradingKey
Thu, Dec 18
Is This the Gray Rhino Scarier Than Fed Rate Hikes? What Yen Rate Hikes Mean for Global Liquidity
TradingKey - Japan, an economy with government debt surpassing 250% of GDP, stands at the precipice where policy contradictions threaten market collapse.TradingKey
Wed, Dec 10
Why Did Strategy's Stock Price Plummet? Can MSTR Reach $1,000?
MicroStrategy (MSTR) stock, despite pressures from Bitcoin volatility and its weak core business, represents the most leveraged investment in a Bitcoin bull market. The company's stock path to $1,000 largely depends on Bitcoin's market performance. Major institutions, including Standard Chartered anTradingKey
Thu, Dec 4
Tradingkey
